|
CREG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.37100000002977E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21979999989641E-07 |
| Normal-vs-Stage2 |
3.180300E-02 |
| Normal-vs-Stage3 |
2.954100E-02 |
| Normal-vs-Stage4 |
3.682800E-01 |
| Stage1-vs-Stage2 |
9.280200E-01 |
| Stage1-vs-Stage3 |
4.075600E-02 |
| Stage1-vs-Stage4 |
4.055100E-03 |
| Stage2-vs-Stage3 |
3.294000E-01 |
| Stage2-vs-Stage4 |
1.169430E-01 |
| Stage3-vs-Stage4 |
3.206000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11489999996295E-06 |
| Normal-vs-AfricanAmerican |
1.230090E-02 |
| Normal-vs-Asian |
8.760400E-01 |
| Caucasian-vs-AfricanAmerican |
5.782400E-01 |
| Caucasian-vs-Asian |
2.938000E-01 |
| AfricanAmerican-vs-Asian |
2.316800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54530000001851E-06 |
| Normal-vs-Female |
2.617900E-03 |
| Male-vs-Female |
3.006000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.402200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.428840E-04 |
| Normal-vs-Age(61-80Yrs) |
6.1980000000017E-05 |
| Normal-vs-Age(81-100Yrs) |
1.140630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.565200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.208000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.628800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.902800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.914600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.949800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.939800E-03 |
| Normal-vs-Grade 2 |
1.46169999992729E-07 |
| Normal-vs-Grade 3 |
3.812200E-04 |
| Normal-vs-Grade 4 |
9.522400E-01 |
| Grade 1-vs-Grade 2 |
4.450800E-01 |
| Grade 1-vs-Grade 3 |
3.957200E-01 |
| Grade 1-vs-Grade 4 |
5.861700E-03 |
| Grade 2-vs-Grade 3 |
5.498000E-02 |
| Grade 2-vs-Grade 4 |
1.763640E-04 |
| Grade 3-vs-Grade 4 |
1.360010E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.26469998310108E-09 |
| Normal-vs-ccB subtype |
3.854100E-02 |
| ccA subtype-vs-ccB subtype |
1.764320E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.355200E-04 |
| Normal-vs-N1 |
5.856200E-01 |
| N0-vs-N1 |
4.544000E-01 |
|
|
